 efficaci haemophilu influenza type polysaccharide-diphtheria toxoid conjug vaccin US children month haemophilu influenza vaccin efficaci studi group vaccin polyribosylribitol phosphat prp capsul haemophilu influenza hib good efficaci children month invas hib diseas efficaci conjugate-prp vaccin age-group effect prp vaccin post-market case-control studi person between oct feb patient hib diseas control children month age socioeconom variabl control patient classmat day-car centr famili acquaint patient diphtheria toxoid conjug hib vaccin week onset ill age household crowd efficaci prp hib vaccin Cl efficaci diphtheria toxoid conjug hib vaccin Cl studi protect efficaci conjug vaccin ideal highlight need addit post-licens studi understand efficaci new product